Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/30/20242:24PMBusiness WireCP Group Inks Lease With Leading Restaurateur for 15,000-SF Elevated Dining Concept at 5POP in Houston, TX
05/30/20242:23PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:TNTTFToronto Dominion Bank (PK)
05/30/20242:23PMBusiness WirePhenom Named Strategic Leader in Fosway 9-Grid™ for Talent Acquisition 2024 for Fourth Consecutive Year
05/30/20242:23PMBusiness WireDiverse Field Crops Cluster: Crop Diversification for a Climate Resilient Agriculture
05/30/20242:22PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:MODModine Manufacturing Co
05/30/20242:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
05/30/20242:22PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
05/30/20242:22PMPR Newswire (Canada)BMO célèbre la Fierté avec le retour des dépôts d'arc-en-ciel
05/30/20242:21PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20242:21PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/30/20242:21PMPR Newswire (US)BMO Celebrates Pride with Return of Rainbow Deposits
05/30/20242:21PMPR Newswire (US)Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
05/30/20242:21PMPR Newswire (Canada)BMO Celebrates Pride with Return of Rainbow Deposits
05/30/20242:20PMPR Newswire (US)Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathyNASDAQ:CALTCalliditas Therapeutics AB
05/30/20242:18PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20242:18PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:LLOBFLloyds Banking Group PLC (PK)
05/30/20242:18PMPR Newswire (US)SoCalGas Declares Preferred DividendsNYSE:SRESempra
05/30/20242:18PMPR Newswire (US)Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathyNASDAQ:CALTCalliditas Therapeutics AB
05/30/20242:17PMEdgar (US Regulatory)Form SD - Specialized disclosure reportAMEX:LGLLGL Group Inc
05/30/20242:17PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:PPIHPerma Pipe International Holdings Inc
05/30/20242:17PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
05/30/20242:17PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
05/30/20242:17PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20242:17PMPR Newswire (US)Pasternack's New RF Fixed Attenuators and Terminations Feature NEX10 Connectorized Design
05/30/20242:17PMPR Newswire (US)The Doctors Company Announces New Tribute Plan Milestone: $175 Million Distributed to Members
05/30/20242:17PMPR Newswire (US)Pasternack's New RF Fixed Attenuators and Terminations Feature NEX10 Connectorized Design
05/30/20242:16PMGlobeNewswire Inc.The Fédération des clubs de motoneigistes du Québec begins celebrating its 50 years of existence
05/30/20242:16PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/30/20242:15PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:THOThor Industries
05/30/20242:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc

Your Recent History

Delayed Upgrade Clock